aprepitant
Term · Oncology and biomedicine · MLC-T-ONC-000694
A drug used with other drugs to prevent nausea and vomiting caused by chemotherapy and nausea and vomiting after surgery. Aprepitant blocks the action of a certain chemical in the central nervous system that may trigger nausea and vomiting. Blocking this chemical may help lessen nausea and vomiting. Aprepitant is a type of antiemetic and a type of substance P/neurokinin 1 receptor antagonist. Also called Cinvanti and Emend.
A small molecule, high-affinity substance P antagonist (SPA) with antiemetic activity. Crossing the blood brain barrier, aprepitant binds selectively to the human substance P/neurokinin 1 receptor in the central nervous system (CNS), thereby inhibiting receptor binding of endogenous substance P and substance P-induced emesis. This agent has little or no affinity for serotonin type 3 (5-HT3), dopamine, and corticosteroid receptors.
| Identifier | MLC-T-ONC-000694 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | Cinvanti; Emend |
| References | NCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-000694",
"term": "aprepitant",
"field": "Oncology and biomedicine",
"definitions": [
"A drug used with other drugs to prevent nausea and vomiting caused by chemotherapy and nausea and vomiting after surgery. Aprepitant blocks the action of a certain chemical in the central nervous system that may trigger nausea and vomiting. Blocking this chemical may help lessen nausea and vomiting. Aprepitant is a type of antiemetic and a type of substance P/neurokinin 1 receptor antagonist. Also called Cinvanti and Emend.",
"A small molecule, high-affinity substance P antagonist (SPA) with antiemetic activity. Crossing the blood brain barrier, aprepitant binds selectively to the human substance P/neurokinin 1 receptor in the central nervous system (CNS), thereby inhibiting receptor binding of endogenous substance P and substance P-induced emesis. This agent has little or no affinity for serotonin type 3 (5-HT3), dopamine, and corticosteroid receptors."
],
"synonyms": [
"Cinvanti",
"Emend"
],
"references": [
"NCI Dictionary of Cancer Terms",
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/aprepitant/"
}
Record 2,396 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.